Geode Capital Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-704,825
| Closed | -$24.6M | – | 4723 |
|
2024
Q1 | $24.6M | Buy |
704,825
+17,465
| +3% | +$611K | ﹤0.01% | 1795 |
|
2023
Q4 | $26.1M | Buy |
687,360
+41,201
| +6% | +$1.57M | ﹤0.01% | 1750 |
|
2023
Q3 | $11.9M | Sell |
646,159
-12,864
| -2% | -$236K | ﹤0.01% | 2157 |
|
2023
Q2 | $17.1M | Buy |
659,023
+49,206
| +8% | +$1.28M | ﹤0.01% | 1962 |
|
2023
Q1 | $11.5M | Buy |
609,817
+34,120
| +6% | +$644K | ﹤0.01% | 2165 |
|
2022
Q4 | $14.2M | Buy |
575,697
+78,890
| +16% | +$1.94M | ﹤0.01% | 2016 |
|
2022
Q3 | $8.92M | Buy |
496,807
+63,688
| +15% | +$1.14M | ﹤0.01% | 2334 |
|
2022
Q2 | $4.92M | Sell |
433,119
-17,321
| -4% | -$197K | ﹤0.01% | 2706 |
|
2022
Q1 | $10M | Buy |
450,440
+20,558
| +5% | +$458K | ﹤0.01% | 2342 |
|
2021
Q4 | $18.8M | Sell |
429,882
-16,341
| -4% | -$714K | ﹤0.01% | 2000 |
|
2021
Q3 | $14.9M | Buy |
446,223
+126,382
| +40% | +$4.21M | ﹤0.01% | 2169 |
|
2021
Q2 | $8.8M | Buy |
319,841
+169,371
| +113% | +$4.66M | ﹤0.01% | 2548 |
|
2021
Q1 | $3.02M | Buy |
150,470
+920
| +0.6% | +$18.5K | ﹤0.01% | 3048 |
|
2020
Q4 | $4.93M | Buy |
149,550
+129,465
| +645% | +$4.27M | ﹤0.01% | 2613 |
|
2020
Q3 | $361K | Buy |
+20,085
| New | +$361K | ﹤0.01% | 3533 |
|